Capital Markets and Commercial Insights: Navigating Opportunities and Challenges in CGTs
Alliance for Regenerative Medicine
Capital Markets and Commercial Insights: Navigating Opportunities and Challenges in CGTs
52:35
Updates on FDA’s Efforts to Accelerated Advances in Cell and Gene Therapy
Alliance for Regenerative Medicine
Updates on FDA’s Efforts to Accelerated Advances in Cell and Gene Therapy
32:47
2025 Cell & Gene State of the Industry Briefing: Introduction and Industry Update
Alliance for Regenerative Medicine
2025 Cell & Gene State of the Industry Briefing: Introduction and Industry Update
31:13
Reshaping Cell and Gene Therapy Manufacturing: ARM Studios Interview with Steve Favaloro
Alliance for Regenerative Medicine
Reshaping Cell and Gene Therapy Manufacturing: ARM Studios Interview with Steve Favaloro
2:53
Strengthening Manufacturing for Cell and Gene Therapies: ARM Studios Interview with Scott Broughton
Alliance for Regenerative Medicine
Strengthening Manufacturing for Cell and Gene Therapies: ARM Studios Interview with Scott Broughton
9:25
Gene Therapy for Hemophilia: ARM Studios Interview with Matthew Kapusta
Alliance for Regenerative Medicine
Gene Therapy for Hemophilia: ARM Studios Interview with Matthew Kapusta
9:44
The Promise of Prime Editing: ARM Studios Interview with Keith Gottesdiener
Alliance for Regenerative Medicine
The Promise of Prime Editing: ARM Studios Interview with Keith Gottesdiener
4:45
Gene Therapy Commercialization: ARM Studios Interview with Faraz Ali
Alliance for Regenerative Medicine
Gene Therapy Commercialization: ARM Studios Interview with Faraz Ali
10:04
Investor Sentiment for Cell and Gene Therapy: ARM Studios Interview with Whitney Ijem
Alliance for Regenerative Medicine
Investor Sentiment for Cell and Gene Therapy: ARM Studios Interview with Whitney Ijem
5:11
CAR-T Cell Therapy from a Patient Perspective: ARM Studios Interview with Bradley Watts
Alliance for Regenerative Medicine
CAR-T Cell Therapy from a Patient Perspective: ARM Studios Interview with Bradley Watts
8:49
Ethical Considerations for Cell & Gene Therapy: ARM Studios Interview with Kevin Fitzgerald SJ, PhD
Alliance for Regenerative Medicine
Ethical Considerations for Cell & Gene Therapy: ARM Studios Interview with Kevin Fitzgerald SJ, PhD
7:20
Overcoming Cell and Gene Therapy Manufacturing Challenges: ARM Studios Interview with Matthew Durdy
Alliance for Regenerative Medicine
Overcoming Cell and Gene Therapy Manufacturing Challenges: ARM Studios Interview with Matthew Durdy
6:17
Value of Cell and Gene Therapy: ARM Studios Interview with Sarah Emond
Alliance for Regenerative Medicine
Value of Cell and Gene Therapy: ARM Studios Interview with Sarah Emond
9:25
The State of Cell and Gene Therapy in Korea: ARM Studios Interview with Duck-Joo Lee
Alliance for Regenerative Medicine
The State of Cell and Gene Therapy in Korea: ARM Studios Interview with Duck-Joo Lee
11:09
Trends in Cell and Gene Therapy Clinical Trials: ARM Studios Interview with Diego Correa
Alliance for Regenerative Medicine
Trends in Cell and Gene Therapy Clinical Trials: ARM Studios Interview with Diego Correa
7:48
Gene Therapy for Rare and Prevalent Conditions: ARM Studios Interview with Curran Simpson
Alliance for Regenerative Medicine
Gene Therapy for Rare and Prevalent Conditions: ARM Studios Interview with Curran Simpson
7:46
Global Access to Cell and Gene Therapy: ARM Studios Interview with Boro Dropulić
Alliance for Regenerative Medicine
Global Access to Cell and Gene Therapy: ARM Studios Interview with Boro Dropulić
5:30
Commercialization Strategies for Cell and Gene Therapies
Alliance for Regenerative Medicine
Commercialization Strategies for Cell and Gene Therapies
1:00:42
Fireside Chat: Jimi Olaghere, Sickle Cell Warrior
Alliance for Regenerative Medicine
Fireside Chat: Jimi Olaghere, Sickle Cell Warrior
36:15
Critical Supply Chain and Logistics Considerations for Cell and Gene Therapy Management
Alliance for Regenerative Medicine
Critical Supply Chain and Logistics Considerations for Cell and Gene Therapy Management
1:00:38
Strategic Manufacturing: Build vs. Buy for Cell and Gene Therapies
Alliance for Regenerative Medicine
Strategic Manufacturing: Build vs. Buy for Cell and Gene Therapies
57:43
OTP Update
Alliance for Regenerative Medicine
OTP Update
58:01
CAR-T: A DEMI-DECADE IN THE REAL WORLD
Alliance for Regenerative Medicine
CAR-T: A DEMI-DECADE IN THE REAL WORLD
59:50
BlueRock Therapeutics
Alliance for Regenerative Medicine
BlueRock Therapeutics
15:08
Satellite Biosciences
Alliance for Regenerative Medicine
Satellite Biosciences
12:35
INNOVATIVE PAYMENT SOLUTIONS – RECENT LEARNINGS FROM GENE THERAPY LAUNCHES
Alliance for Regenerative Medicine
INNOVATIVE PAYMENT SOLUTIONS – RECENT LEARNINGS FROM GENE THERAPY LAUNCHES
1:00:27
THE EU JOINT HEALTH TECHNOLOGY ASSESSMENT: A FIT FOR PURPOSE JCA?
Alliance for Regenerative Medicine
THE EU JOINT HEALTH TECHNOLOGY ASSESSMENT: A FIT FOR PURPOSE JCA?
1:02:19
WELCOME REMARKS
Alliance for Regenerative Medicine
WELCOME REMARKS
18:55
THE FUTURE OF GENETIC MEDICINE
Alliance for Regenerative Medicine
THE FUTURE OF GENETIC MEDICINE
57:41
ARM STRATEGIC INITIATIVES
Alliance for Regenerative Medicine
ARM STRATEGIC INITIATIVES
14:37
A FORECAST ON THE 2024 CGTX LANDSCAPE
Alliance for Regenerative Medicine
A FORECAST ON THE 2024 CGTX LANDSCAPE
44:07
REDEFINING THE GLOBAL REGULATORY LANDSCAPE FOR ATMP COMMERCIAL APPROVAL: 1 APPROVAL TO RULE THEM ALL
Alliance for Regenerative Medicine
REDEFINING THE GLOBAL REGULATORY LANDSCAPE FOR ATMP COMMERCIAL APPROVAL: 1 APPROVAL TO RULE THEM ALL
46:29
TISSUE REPAIR AND REGENERATION – REFLECTING ON PROGRESS FOR NOVEL TISSUE THERAPEUTICS
Alliance for Regenerative Medicine
TISSUE REPAIR AND REGENERATION – REFLECTING ON PROGRESS FOR NOVEL TISSUE THERAPEUTICS
31:10
FIRESIDE CHAT: THE PATIENT ACCESS ENVIRONMENT FOR ATMPS IN EUROPE – THE ROLE OF EVIDENCE GENERATION
Alliance for Regenerative Medicine
FIRESIDE CHAT: THE PATIENT ACCESS ENVIRONMENT FOR ATMPS IN EUROPE – THE ROLE OF EVIDENCE GENERATION
32:52
TRANSLATING EARLY RESEARCH INTO PROMISING NEW ATMPS FOR PATIENTS THROUGH PUBLIC-PRIVATE PARTNERSHIPS
Alliance for Regenerative Medicine
TRANSLATING EARLY RESEARCH INTO PROMISING NEW ATMPS FOR PATIENTS THROUGH PUBLIC-PRIVATE PARTNERSHIPS
43:32
DEVELOPING THE ATMP ECOSYSTEM OF THE FUTURE
Alliance for Regenerative Medicine
DEVELOPING THE ATMP ECOSYSTEM OF THE FUTURE
1:01:10
ETHICS IN GENE AND CELL THERAPY
Alliance for Regenerative Medicine
ETHICS IN GENE AND CELL THERAPY
59:24
FEATURED KEYNOTE SPEAKER: DR. MASSIMO DOMINICI
Alliance for Regenerative Medicine
FEATURED KEYNOTE SPEAKER: DR. MASSIMO DOMINICI
30:53
STRATEGIC INVESTMENT PERSPECTIVES IN THE EVOLVING EUROPEAN AND GLOBAL ATMP LANDSCAPE
Alliance for Regenerative Medicine
STRATEGIC INVESTMENT PERSPECTIVES IN THE EVOLVING EUROPEAN AND GLOBAL ATMP LANDSCAPE
1:01:08
INNOVATIVE APPROACHES: DECENTRALIZED MANUFACTURING OF ATMPS
Alliance for Regenerative Medicine
INNOVATIVE APPROACHES: DECENTRALIZED MANUFACTURING OF ATMPS
1:01:17
PolTREG
Alliance for Regenerative Medicine
PolTREG
17:52
MaxCyte
Alliance for Regenerative Medicine
MaxCyte
14:42
Cellistic
Alliance for Regenerative Medicine
Cellistic
15:20
GeneFab
Alliance for Regenerative Medicine
GeneFab
0:23
L7 Informatics
Alliance for Regenerative Medicine
L7 Informatics
14:46
Immpact Bio
Alliance for Regenerative Medicine
Immpact Bio
15:44
Forge Biologics
Alliance for Regenerative Medicine
Forge Biologics
13:20
Splice Bio
Alliance for Regenerative Medicine
Splice Bio
14:36
Wacker Biotech
Alliance for Regenerative Medicine
Wacker Biotech
15:39
SmartCella
Alliance for Regenerative Medicine
SmartCella
14:37
CTI Clinical Trial & Consulting Services
Alliance for Regenerative Medicine
CTI Clinical Trial & Consulting Services
15:05
CoJourney
Alliance for Regenerative Medicine
CoJourney
20:09
Nanite
Alliance for Regenerative Medicine
Nanite
13:12
Carisma Therapeutics
Alliance for Regenerative Medicine
Carisma Therapeutics
15:49
Allarta Life Science
Alliance for Regenerative Medicine
Allarta Life Science
15:10
New Frontiers in Immuno-oncology for Solid Tumor Treatment
Alliance for Regenerative Medicine
New Frontiers in Immuno-oncology for Solid Tumor Treatment
1:01:35
Genethon
Alliance for Regenerative Medicine
Genethon
13:31
C3I Center
Alliance for Regenerative Medicine
C3I Center
17:52
Laverock Therapeutics
Alliance for Regenerative Medicine
Laverock Therapeutics
15:36
Mekonos
Alliance for Regenerative Medicine
Mekonos
15:38
Aspect Biosystems
Alliance for Regenerative Medicine
Aspect Biosystems
16:50
Sernova
Alliance for Regenerative Medicine
Sernova
19:39
Vesigen Therapeutics
Alliance for Regenerative Medicine
Vesigen Therapeutics
14:59
Avectas Limited
Alliance for Regenerative Medicine
Avectas Limited
14:55
Rocket Pharmaceuticals
Alliance for Regenerative Medicine
Rocket Pharmaceuticals
15:58
Adverum Biotechnologies
Alliance for Regenerative Medicine
Adverum Biotechnologies
14:52
Novartis Contract Manufacturing
Alliance for Regenerative Medicine
Novartis Contract Manufacturing
13:16
QuTEM
Alliance for Regenerative Medicine
QuTEM
13:49
Verigraft
Alliance for Regenerative Medicine
Verigraft
15:13
Phase Holographic Imaging
Alliance for Regenerative Medicine
Phase Holographic Imaging
11:25
Cryoport Systems
Alliance for Regenerative Medicine
Cryoport Systems
12:25
Invetech
Alliance for Regenerative Medicine
Invetech
10:03
Sensorion
Alliance for Regenerative Medicine
Sensorion
13:33
Entos Pharmaceuticals
Alliance for Regenerative Medicine
Entos Pharmaceuticals
14:39
Trakcel
Alliance for Regenerative Medicine
Trakcel
15:57
Advances in Targeting Autoimmune Disease
Alliance for Regenerative Medicine
Advances in Targeting Autoimmune Disease
57:32
MeiraGTx
Alliance for Regenerative Medicine
MeiraGTx
13:51
Aldevron
Alliance for Regenerative Medicine
Aldevron
16:50
SK Pharmteco
Alliance for Regenerative Medicine
SK Pharmteco
13:30
Precigen
Alliance for Regenerative Medicine
Precigen
19:38
Cell and Gene Therapy Catapult
Alliance for Regenerative Medicine
Cell and Gene Therapy Catapult
12:55
Virocell Biologics
Alliance for Regenerative Medicine
Virocell Biologics
7:21
StemSight
Alliance for Regenerative Medicine
StemSight
13:52
SparingVision
Alliance for Regenerative Medicine
SparingVision
14:40
Vivet Therapeutics
Alliance for Regenerative Medicine
Vivet Therapeutics
9:38
Astellas Pharma
Alliance for Regenerative Medicine
Astellas Pharma
15:57
Aurion Biotech
Alliance for Regenerative Medicine
Aurion Biotech
14:47
Accelerated Biosciences
Alliance for Regenerative Medicine
Accelerated Biosciences
14:11
Aviado Bio
Alliance for Regenerative Medicine
Aviado Bio
15:21
Treefrog Therapeutics
Alliance for Regenerative Medicine
Treefrog Therapeutics
14:25
Exo Biologics
Alliance for Regenerative Medicine
Exo Biologics
12:59
Advanced Medicine Partners
Alliance for Regenerative Medicine
Advanced Medicine Partners
16:41
Autolus
Alliance for Regenerative Medicine
Autolus
11:12
UniQure
Alliance for Regenerative Medicine
UniQure
14:52
Coave Therapeutics
Alliance for Regenerative Medicine
Coave Therapeutics
14:22
Arbor Biotechnologies
Alliance for Regenerative Medicine
Arbor Biotechnologies
15:13
Ray Therapeutics
Alliance for Regenerative Medicine
Ray Therapeutics
16:29
Kiji Therapeutics
Alliance for Regenerative Medicine
Kiji Therapeutics
13:54
Stimuliver
Alliance for Regenerative Medicine
Stimuliver
13:57
Vor Bio
Alliance for Regenerative Medicine
Vor Bio
15:00